France welcomes availability of ARVs in developing countries

Paris, France (PANA) - France has welcomed the agreement between the pharmaceutical company, Gilead and the Community patent for drugs, which will allow AIDS patients more access to antiretroviral (ARV) medication in developing countries, spokesman for the French Ministry of Foreign Affairs, Bernard Valero, said here Wednesday.

Speaking at a press briefing, Mr. Valero said it was essential that patients have access to treatment, hoping to achieve the Millennium Development Goals (MDGs) on health.

"France reiterates that it has, from the beginning, supported the initiative launched by the International Facility for Purchase of Medicines (UNITAID) on the community patent initiative now only able to allow access to all those who need it the most modern medicines, to effectively fight against AIDS," said the spokesman for the Quai d'Orsay.

He also reiterated the full support of his country to UNITAID, launched to enable developing countries, particularly those in Africa, access to medicines to fight against malaria, tuberculosis and AIDS.

Despite the significant progress made this year, more than half of AIDS patients living in Africa still lack access to ARVs.
-0- PANA SEI/SSB/AAKA/BOS 13July2011

13 july 2011 17:19:36




xhtml CSS